{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T08:10:37Z","timestamp":1685866237289},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.transproceed.2010.08.040","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:24:13Z","timestamp":1290245053000},"page":"3815-3819","source":"Crossref","is-referenced-by-count":3,"title":["Use of Genetically Modified Allograft to Deliver Local Immunomodulatory Molecule with Minimal Systemic Toxicity in a Rat Model of Allogeneic Skin Flap Transplantation"],"prefix":"10.1016","volume":"42","author":[{"given":"S.","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Z.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.08.040_bib1","doi-asserted-by":"crossref","first-page":"7e","DOI":"10.1097\/PRS.0b013e318193467d","article-title":"Tolerance and future directions for composite tissue allograft transplants: part II","volume":"123","author":"Siemionow","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.transproceed.2010.08.040_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.transproceed.2009.01.026","article-title":"The history of human composite tissue allo-transplantation","volume":"41","author":"Tobin","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.040_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaci.2008.01.002","article-title":"Costimulation blockade in autoimmunity and transplantation","volume":"121","author":"Vincenti","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transproceed.2010.08.040_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1471-4906(01)02127-5","article-title":"OX40: targeted immunotherapy; implications for tempering autoimmunity and enhancing vaccines","volume":"23","author":"Weinberg","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.transproceed.2010.08.040_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00005-008-0032-3","article-title":"Is it wise to target the late costimulatory molecule OX40 as therapeutic target?","volume":"56","author":"Cavanagh","year":"2008","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.transproceed.2010.08.040_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cellbi.2009.02.001","article-title":"TNF superfamily: costimulation and clinical applications","volume":"33","author":"Vinay","year":"2009","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.transproceed.2010.08.040_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1189\/jlb.72.3.522","article-title":"In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions","volume":"72","author":"Taylor","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.transproceed.2010.08.040_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00007890-200003150-00009","article-title":"Additive efficacy of CTLA4Ig and OX40Ig secreted by genetically modified grafts","volume":"69","author":"Brady","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.040_bib9","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1016\/j.transproceed.2005.10.117","article-title":"Blockade of both CD28\/B7 and OX40\/OX40L co-stimulatory signal pathways prolongs the survival of islet xenografts","volume":"37","author":"Wang","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.040_bib10","first-page":"801","article-title":"OX40(CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival","volume":"78","author":"Curry","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.08.040_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PRS.0b013e31816ff6aa","article-title":"Using genetically modified microvascular free flaps to deliver local cancer immunotherapy with minimal systemic toxicity","volume":"121","author":"Dempsey","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.transproceed.2010.08.040_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.prs.0000220466.27521.22","article-title":"Biologic brachytherapy: ex vivo transduction of microvascular beds for efficient, targeted gene therapy","volume":"118","author":"Michaels","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.transproceed.2010.08.040_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.sap.0000122652.81844.37","article-title":"Ex vivo transduction of microvascular free flaps for localized peptide delivery","volume":"52","author":"Michaels","year":"2004","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.transproceed.2010.08.040_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.08.040_bib15","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1600-6143.2008.02243.x","article-title":"The Banff 2007 working classification of skin-containing composite tissue allograft pathology","volume":"8","author":"Cendales","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.08.040_bib16","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1097\/PRS.0b013e318191bcbd","article-title":"Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model","volume":"123","author":"Solari","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.transproceed.2010.08.040_bib17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4049\/jimmunol.179.3.1427","article-title":"Cutting edge: OX40 inhibits TGF-beta and antigen-driven conversion of na\u00efve CD4 T cells into CD25+Foxp3+ T cells","volume":"179","author":"So","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2010.08.040_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOT.0b013e3282f3def3","article-title":"Novel roles of OX40 in the allograft response","volume":"13","author":"Demirci","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2010.08.040_bib19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00417-007-0629-y","article-title":"The influence of inducible costimulator fusion protein (ICOSIg) gene transfer on corneal allograft survival","volume":"245","author":"Fabian","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.transproceed.2010.08.040_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.transproceed.2009.01.021","article-title":"Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model","volume":"41","author":"Pradka","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.08.040_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0966-3274(02)00153-3","article-title":"Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival","volume":"11","author":"Akamaru","year":"2003","journal-title":"Transplant Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510012649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510012649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T07:28:33Z","timestamp":1685863713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510012649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0041134510012649"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.08.040","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}